| Literature DB >> 32600331 |
Ying Yu1, Gong Zhang1, Tao Han2, Hailiang Huang3.
Abstract
BACKGROUND: The network pharmacology method was used to predict the active components of Banxia Xiexin decoction, its targets and the key signalling pathways that are activated in the treatment of depression and ulcerative colitis to explore the common mechanism.Entities:
Keywords: Banxia Xiexin decoction; Depression; Module analysis; Network pharmacology; Signal pathway; Target; Ulcerative colitis
Year: 2020 PMID: 32600331 PMCID: PMC7325019 DOI: 10.1186/s12906-020-02988-3
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671
Fig. 1Venn diagram of drug-disease intersection target of Banxia Xiexin decoction for depression and ulcerative colitis
Fig. 2PPI Network Diagram of Common Targets
Fig. 3Network module analysis of Banxia Xiexin Decoction in the treatment of depression and ulcerative colitis
Results of enriched GO biological process and KEGG signal pathway analysis results of for module A ~ D (only top three are reserved)
| A | GO:0045944 ~ positive regulation of transcription from RNA polymerase II promoter | 1.84E-10 | hsa05200:Pathways in cancer | 3.42E-10 |
| GO:0045429 ~ positive regulation of nitric oxide biosynthetic process | 2.50E-10 | hsa05205:Proteoglycans in cancer | 4.86E-10 | |
| GO:0008284 ~ positive regulation of cell proliferation | 1.07E-09 | hsa00590:Arachidonic acid metabolism | 6.48E-03 | |
| B | GO:0006367 ~ transcription initiation from RNA polymerase II promoter | 1.92E-11 | hsa04066:HIF-1 signaling pathway | 7.71E-08 |
| GO:0045429 ~ positive regulation of nitric oxide biosynthetic process | 1.11E-10 | hsa00590:Arachidonic acid metabolism | 1.86E-03 | |
| GO:0048146 ~ positive regulation of fibroblast proliferation | 3.81E-08 | hsa04064:NF-kappa B signaling pathway | 4.83E-02 | |
| C | GO:0005887 ~ integral component of plasma membrane | 1.25E-07 | hsa04080:Neuroactive ligand-receptor interaction | 2.01E-06 |
| GO:0005886 ~ plasma membrane | 6.80E-06 | hsa04726:Serotonergic synapse | 5.14E-03 | |
| GO:0007268 ~ chemical synaptic transmission | 1.53E-04 | hsa04020:Calcium signaling pathway | 1.30E-02 | |
| D | GO:0006805 ~ xenobiotic metabolic process | 2.07E-07 | hsa00982:Drug metabolism - cytochrome P450 | 1.06E-04 |
| GO:0008202 ~ steroid metabolic process | 3.39E-06 | hsa00980:Metabolism of xenobiotics by cytochrome P450 | 1.36E-04 | |
| GO:0042908 ~ xenobiotic transport | 9.81E-06 | hsa00830:Retinol metabolism | 3.65E-03 |
Fig. 4Results of the analysis of enriched GO biological processes (a) and KEGG pathways (b) of common targets of Banxia Xiexin decoction in the treatment of depression and ulcerative colitis
Eight key targets of Banxia Xiexin decoction in common pathways involved in the treatment of depression and ulcerative colitis
| ALB | P02768 | Serum albumin | PTGS2 | P35354 | Prostaglandin G/H synthase 2 |
| IL6 | P05231 | Interleukin-6 | MAPK1 | P28482 | Mitogen-activated protein kinase 1 |
| VEGFA | P15692 | Vascular endothelial growth factor A | STAT3 | P40763 | Signal transducer and activator of transcription 3 |
| TNF | P01375 | Tumor necrosis factor | EGFR | P00533 | Epidermal growth factor receptor |
Fig. 5Target-tissue network (a) and target-subcellular network (b) of eight key targets in common pathways regulated by Banxia xiexin decoction in the treatment of depression and ulcerative colitis
Protein class of eight key targets for common pathways of Banxia Xiexin decoction in the treatment of depression and ulcerative colitis
| ALB | transfer/carrier protein | PTGS2 | oxidoreductase | ||
| IL6 | None | MAPK1 | transferase | ||
| VEGFA | signaling molecule | STAT3 | transcription factor | ||
| TNF | signaling molecule | EGFR | None |